SCHEMBL2190167

SCHEMBL2190167

O=C1CCC(=O)C(c2ccc(Br)cc2)N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 4/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
THRB P10828 1/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
LMNA P02545 1/20 0.36
NPC1 O15118 2/20 0.36
GAA P10253 1/20 0.36
ESR1 P03372 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
KDM1A O60341 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9024296 0.81 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL6098240 0.81 TP53 (0.44) SMN1; SMN2ALDH1A1MEN1KMT2AGAA
SCHEMBL7480927 0.80 DDB1 (0.43) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD
SCHEMBL8530679 0.79 KMT2A (0.49) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL2188799 0.78 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MAPTKDM4ETHRB
SCHEMBL2188794 0.78 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MAPTKDM4ETHRB
SCHEMBL22201147 0.77 PDE4A (0.44) SMN1; SMN2ALDH1A1MAPTKDM4ETHRB
SCHEMBL4142288 0.77 PDE4A (0.44) SMN1; SMN2ALDH1A1MAPTKDM4ETHRB
SCHEMBL482061 0.77 PDE4A (0.44) SMN1; SMN2ALDH1A1MAPTKDM4ETHRB
SCHEMBL8530265 0.77 DDB1 (0.50) SMN1; SMN2ALDH1A1MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361246-A1 OXOPIPERIDINYL AND PYRANYL SULFONAMIDES AS AMPA POTENTIATORS Pfizer Inc. (US) 2011-08-31 EP disclosed
US-20110172297-A1 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof PFIZER INC 2011-07-14 US disclosed
WO-2010038167-A1 OXOPIPERIDINYL AND PYRANYL SULFONAMIDES AS AMPA POTENTIATORS PFIZER INC. (US) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172297-A1 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof GRIK5, GABRE, GRIK2 SMN1; SMN2 2115/4885ALDH1A1 1118/4885MAPT 3053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.